This was a new position; the IBB stake now accounts for 8.7% of Florin Court Capital LLP’s 13F AUM Top five holdings after ...
Anbio Biotechnology, a global medical technology company focused on in vitro diagnostics, has successfully closed its initial public offering of 1,600,000 Class A ordinary shares at a price of $5.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback